Shire







pdufa will speak volumnes !! frankie has breakthrough orphan accelerated blockbuster approval guaranteed !! shire to buyout at 60 per share,

Heard from someone outside company that NPS is definitely for sale (no surprise there) and Shire is leading candidate. Transaction should be formalized by end of year. Field force might be safe but HQ folks should be looking now so that once they get their package they will have something else lined up. Although not bad idea for us in field to be looking as well. Time will tell.
 












Shire will pay top dollar for us and squeeze every last penny. Nobody will be safe and it is a toxic place to work nowadays. Our execs will make a fortune though.

That's the way it works. Agree that regardless of what happens this Friday, the atmosphere is toxic as we all see the writing on the wall. Crazy how fast things change.
 






That's the way it works. Agree that regardless of what happens this Friday, the atmosphere is toxic as we all see the writing on the wall. Crazy how fast things change.

You all need to speak up so all these poor slugs thinking this company is the savior get a clue. They want to believe the employees that left were the problem or that the new drug will be different (better to sell??) or that they wont be the person who doesn't make money. No one talks about the toxic atmosphere and the total turn about from launch to year one.

And what about that idiot JM? Fill in the masses on him.
 






























Post announcement yesterday it is taking a hit.

NPS Pharmaceuticals, Inc. (NPSP), a biopharmaceutical company engaged in the development of therapeutic products in the US, was downgraded by Goldman Sachs (GS) analysts to ‘Neutral’ from a ‘Buy’ rating Friday. NPS Pharmaceuticalsshares were down 7.39% at $26.82 in early trade, moving within a 52-week range of $21.60 – $39.68.

Notable Downgrades: Jakks Pacific (JAKK), Pandora Media (P), NPS Pharmaceuticals (NPSP), Synaptics (SYNA)